FDA Inspection
Memorial Hermann Texas Medical CenterMemorial Hermann Texas Medical Center – FDA Inspection, Nov 16, 2017
Record Details
This FDA Inspection record concerns Memorial Hermann Texas Medical Center, with an inspection on November 16, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · fcf1eced-1939-4c2d-ba95-5b429234b2a3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031447
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Memorial Hermann Texas Medical Center
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 18, 2024 | Not classified | Dallas District Office | |
| August 26, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 10, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 14, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 26, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Memorial Hermann Texas Medical Center
- FDA Inspection 1256951 - 2024-11-18
- FDA Inspection 1180562 - 2022-08-26
- FDA Inspection 985572 - 2016-06-10
- FDA Inspection 862714 - 2014-01-14
- FDA Inspection 773663 - 2012-03-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.